Go Pro

MarketBeat Instant News Alerts

BMO Capital Markets Forecasts Strong Price Appreciation for Alliance Laundry (NYSE:ALH) Stock

BMO Capital Markets lifted their price target on shares of Alliance Laundry from $30.00 to $31.00 and gave the company an "outperform" rating in a research report on Monday.

NYSE:ALH
Read BMO Capital Markets Forecasts Strong Price Appreciation for Alliance Laundry (NYSE:ALH) Stock
JBS logo with Consumer Staples background

JBS (NYSE:JBS) Given New $17.00 Price Target at Stephens

Stephens dropped their price target on shares of JBS from $18.00 to $17.00 and set an "overweight" rating on the stock in a research note on Monday.

NYSE:JBS
Read JBS (NYSE:JBS) Given New $17.00 Price Target at Stephens
Watsco logo with Industrials background

Watsco's (WSO) "Overweight" Rating Reiterated at Stephens

Stephens reiterated an "overweight" rating and issued a $485.00 target price on shares of Watsco in a research note on Monday.

NYSE:WSO
Read Watsco's (WSO) "Overweight" Rating Reiterated at Stephens
Protagonist Therapeutics logo with Healthcare background

Protagonist Therapeutics (NASDAQ:PTGX) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

BMO Capital Markets upped their price target on Protagonist Therapeutics from $112.00 to $178.00 and gave the company an "outperform" rating in a research note on Monday.

NASDAQ:PTGX
Read Protagonist Therapeutics (NASDAQ:PTGX) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
RCM Technologies logo with Industrials background

RCM Technologies (NASDAQ:RCMT) Price Target Raised to $45.00 at Benchmark

Benchmark boosted their price objective on shares of RCM Technologies from $36.00 to $45.00 and gave the stock a "buy" rating in a research note on Monday.

NASDAQ:RCMT
Read RCM Technologies (NASDAQ:RCMT) Price Target Raised to $45.00 at Benchmark
Regeneron Pharmaceuticals logo with Healthcare background

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $824.00 at Leerink Partners

Leerink Partners increased their target price on shares of Regeneron Pharmaceuticals from $641.00 to $824.00 and gave the stock a "market perform" rating in a research note on Monday.

NASDAQ:REGN
Read Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $824.00 at Leerink Partners

Trending News

All MarketBeat Instant News Alerts

Big Sky Industrial Inc. Common Stock logo with Energy background

Big Sky Industrial Inc. Common Stock (NASDAQ:BSIN) Raised to Buy at Johnson Rice

NASDAQ:BSIN
Read Big Sky Industrial Inc. Common Stock (NASDAQ:BSIN) Raised to Buy at Johnson Rice
Arthur J. Gallagher & Co. logo with Finance background

Arthur J. Gallagher & Co. (NYSE:AJG) Price Target Raised to $300.00 at Argus

NYSE:AJG
Read Arthur J. Gallagher & Co. (NYSE:AJG) Price Target Raised to $300.00 at Argus
AppLovin logo with Technology background

AppLovin (NASDAQ:APP) Price Target Cut to $440.00 by Analysts at Benchmark

NASDAQ:APP
Read AppLovin (NASDAQ:APP) Price Target Cut to $440.00 by Analysts at Benchmark
Cardiol Therapeutics logo with Healthcare background

Canaccord Genuity Group Issues Positive Forecast for Cardiol Therapeutics (NASDAQ:CRDL) Stock Price

NASDAQ:CRDL
Read Canaccord Genuity Group Issues Positive Forecast for Cardiol Therapeutics (NASDAQ:CRDL) Stock Price
Elmet Group logo with Industrials background

Elmet Group (NASDAQ:ELMT) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

NASDAQ:ELMT
Read Elmet Group (NASDAQ:ELMT) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
Quanterix logo with Healthcare background

Quanterix (NASDAQ:QTRX) Price Target Cut to $3.00 by Analysts at Canaccord Genuity Group

NASDAQ:QTRX
Read Quanterix (NASDAQ:QTRX) Price Target Cut to $3.00 by Analysts at Canaccord Genuity Group
Surf Air Mobility logo with Industrials background

Surf Air Mobility (NYSE:SRFM) Price Target Lowered to $1.00 at Canaccord Genuity Group

NYSE:SRFM
Read Surf Air Mobility (NYSE:SRFM) Price Target Lowered to $1.00 at Canaccord Genuity Group
Bioventus logo with Healthcare background

Bioventus (NASDAQ:BVS) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

NASDAQ:BVS
Read Bioventus (NASDAQ:BVS) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
Enovis logo with Healthcare background

Canaccord Genuity Group Lowers Enovis (NYSE:ENOV) Price Target to $45.00

NYSE:ENOV
Read Canaccord Genuity Group Lowers Enovis (NYSE:ENOV) Price Target to $45.00
Entain logo with Consumer Discretionary background

Deutsche Bank Aktiengesellschaft Cuts Entain (LON:ENT) Price Target to GBX 914

LON:ENT
Read Deutsche Bank Aktiengesellschaft Cuts Entain (LON:ENT) Price Target to GBX 914
GB Group logo with Technology background

Deutsche Bank Aktiengesellschaft Cuts GB Group (LON:GBG) Price Target to GBX 345

LON:GBG
Read Deutsche Bank Aktiengesellschaft Cuts GB Group (LON:GBG) Price Target to GBX 345
SSP Group logo with Consumer Discretionary background

Deutsche Bank Aktiengesellschaft Reaffirms Buy Rating for SSP Group (LON:SSPG)

LON:SSPG
Read Deutsche Bank Aktiengesellschaft Reaffirms Buy Rating for SSP Group (LON:SSPG)
Pulse Biosciences logo with Healthcare background

Pulse Biosciences, Inc (NASDAQ:PLSE) Given Average Rating of "Moderate Buy" by Brokerages

NASDAQ:PLSE
Read Pulse Biosciences, Inc (NASDAQ:PLSE) Given Average Rating of "Moderate Buy" by Brokerages
York Space Systems logo with Industrials background

York Space Systems (NYSE:YSS) Receives "Neutral" Rating from JPMorgan Chase & Co.

NYSE:YSS
Read York Space Systems (NYSE:YSS) Receives "Neutral" Rating from JPMorgan Chase & Co.
Amcor logo with Materials background

Amcor (NYSE:AMCR) Receives Neutral Rating from JPMorgan Chase & Co.

NYSE:AMCR
Read Amcor (NYSE:AMCR) Receives Neutral Rating from JPMorgan Chase & Co.
Sunrun logo with Utilities background

Sunrun (NASDAQ:RUN) Receives "Sell" Rating from Glj Research

NASDAQ:RUN
Read Sunrun (NASDAQ:RUN) Receives "Sell" Rating from Glj Research
Eyepoint Pharmaceuticals logo with Healthcare background

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Given "Buy" Rating at Chardan Capital

NASDAQ:EYPT
Read Eyepoint Pharmaceuticals (NASDAQ:EYPT) Given "Buy" Rating at Chardan Capital
Nano-X Imaging logo with Healthcare background

Nano-X Imaging (NASDAQ:NNOX) Given Overweight Rating at Cantor Fitzgerald

NASDAQ:NNOX
Read Nano-X Imaging (NASDAQ:NNOX) Given Overweight Rating at Cantor Fitzgerald
MiMedx Group logo with Healthcare background

MiMedx Group's (MDXG) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

NASDAQ:MDXG
Read MiMedx Group's (MDXG) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
Bioventus logo with Healthcare background

Bioventus' (BVS) "Overweight" Rating Reiterated at Cantor Fitzgerald

NASDAQ:BVS
Read Bioventus' (BVS) "Overweight" Rating Reiterated at Cantor Fitzgerald
Texas Instruments logo with Technology background

Texas Instruments' (TXN) Neutral Rating Reiterated at Cantor Fitzgerald

NASDAQ:TXN
Read Texas Instruments' (TXN) Neutral Rating Reiterated at Cantor Fitzgerald
onsemi logo with Technology background

onsemi's (ON) Neutral Rating Reaffirmed at Cantor Fitzgerald

NASDAQ:ON
Read onsemi's (ON) Neutral Rating Reaffirmed at Cantor Fitzgerald
NXP Semiconductors logo with Technology background

Cantor Fitzgerald Reaffirms Overweight Rating for NXP Semiconductors (NASDAQ:NXPI)

NASDAQ:NXPI
Read Cantor Fitzgerald Reaffirms Overweight Rating for NXP Semiconductors (NASDAQ:NXPI)
Microchip Technology logo with Technology background

Microchip Technology's (MCHP) "Overweight" Rating Reiterated at Cantor Fitzgerald

NASDAQ:MCHP
Read Microchip Technology's (MCHP) "Overweight" Rating Reiterated at Cantor Fitzgerald

Featured Articles and Offers

Alert Categories

All Alerts